Erdafitinib is a tyrosine kinase inhibitor, a targeted therapy indicated for the treatment of some locally advanced or metastatic urothelial cancers.
What's New
Trastuzumab-dttb (Ontruzant®) is a biosimilar monoclonal antibody used in the treatment of some types of breast and gastric cancer.
In this webinar, Dr. Neil Taunk, MD, MS, Assistant Professor and Chief of Gynecologic Radiation Oncology at Penn Medicine, provides an overview of proton radiation therapy for gynecologic cancers.
Trastuzumab and Hyaluronidase-oysk (Herceptin Hylecta™) is a medication used in the treatment of some cases of breast cancer.
OncoLink Apps
Blogs
OncoLink's Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.
View all Blogs
Brain Tumor Awareness Month
May is Brain Tumor Awareness Month, with the goal of raising awareness of the disease and giving patients and their families the opportunity to share education and information and to help change what the experience is like. Learn more about brain tumors, treatment and support resources on OncoLink.
Need Cancer Patient Education Tools?
Our award winning cancer education content is now available for licensing and syndication.
I Wish U Knew!
I Wish U Knew is a video series featuring oncology professionals and survivors discussing what they wish patients and the public knew about cancer.